Predict your next investment

Venture Capital
innverproductpartners.com

See what CB Insights has to offer

Investments

2

Funds

1

About InnerProduct Partners

InnerProduct Partners is a specialized fund manager supporting an underserved market for early-stage U.S.-based technology companies in IT, Materials, Energy, and Healthcare. InnerProduct Partners seeks to create value for entrepreneurs and limited partners by investing in compelling commercial opportunities that align with urgent needs of non-dilutive capital sources. In addition, the InnerProduct Partners team, which combines broad technical and industry experience, actively deploys with entrepreneurs to accelerate technology de-risking and the delivery of disruptive products to market. This disciplined human and financial capital approach is expected to benefit both founder-entrepreneurs and investors, enabling the rapid commercialization of new technologies and superior financial returns.

InnerProduct Partners Headquarter Location

750 Battery Street 7th Floor

San Francisco, California, 94111,

United States

415-273-6806

Predict your next investment

The CB Insights tech market intelligence platform analyzes millions of data points on venture capital, startups, patents , partnerships and news mentions to help you see tomorrow's opportunities, today.

Latest InnerProduct Partners News

Koya Medical Closes $11M Series A Financing Round

Jan 15, 2021

Koya Medical , an Oakland, Calif.-based healthcare company focused on treating lymphedema and vein disease, closed an $11m Series A funding. The round was led by Arboretum Ventures with participation from Scientific Health Development Partners, Zühlke Ventures, Bolt, and InnerProduct Partners. In conjunction with the funding, Jan Garfinkle, founder and managing director of Arboretum Ventures, will join the board of directors and Josh Baltzell will continue as the Chairman. Founded in 2018 and led by Andy Doraiswamy, PhD, President and CEO, Koya Medical recently received FDA-clearance for the Dayspring™ product platform, a prescription only active wearable compression system for the treatment of lymphedema and venous insufficiency. Dayspring is the first FDA-cleared digitally connected system designed to enable patient mobility during use. FinSMEs

InnerProduct Partners Investments

2 Investments

InnerProduct Partners has made 2 investments. Their latest investment was in TendoNova as part of their Unattributed VC on October 10, 2021.

CBI Logo

InnerProduct Partners Investments Activity

investments chart

Date

Round

Company

Amount

New?

Co-Investors

Sources

10/7/2021

Unattributed VC

TendoNova

$0.17M

Yes

1

12/30/2020

Series A

Subscribe to see more

$99M

Subscribe to see more

10

Date

10/7/2021

12/30/2020

Round

Unattributed VC

Series A

Company

TendoNova

Subscribe to see more

Amount

$0.17M

$99M

New?

Yes

Subscribe to see more

Co-Investors

Sources

1

10

InnerProduct Partners Fund History

1 Fund History

InnerProduct Partners has 1 fund, including InnerProduct Partners Fund.

Closing Date

Fund

Fund Type

Status

Amount

Sources

1/14/2015

InnerProduct Partners Fund

Multi-Stage Venture Capital

Open

$5.99M

1

Closing Date

1/14/2015

Fund

InnerProduct Partners Fund

Fund Type

Multi-Stage Venture Capital

Status

Open

Amount

$5.99M

Sources

1

InnerProduct Partners Team

7 Team Members

InnerProduct Partners has 7 team members, including current General Partner, Pete Haal.

Name

Work History

Title

Status

Joshua Silber

VantagePoint Capital Partners, Cofra Holding, and Credit Suisse

Founder

Current

Pete Haal

General Partner

Current

Peter Haaland

General Partner

Current

Doug Kirkpatrick

General Partner

Current

Douglas Kirkpatrick

General Partner

Current

Name

Joshua Silber

Pete Haal

Peter Haaland

Doug Kirkpatrick

Douglas Kirkpatrick

Work History

VantagePoint Capital Partners, Cofra Holding, and Credit Suisse

Title

Founder

General Partner

General Partner

General Partner

General Partner

Status

Current

Current

Current

Current

Current

CB Insights uses Cookies

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.